Sana Johnson-Quijada
Psychiatry · Temecula, CANPI 1194882860
Payments from drug & device makers
Across 1,306 payments — averaging $1948.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$801K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$541K
- Sage Therapeutics, LLC$516K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$169K
- Boehringer Ingelheim$158K
- Alkermes, Inc.$149K
- plus $212K from 20 others
Across 6 payments — averaging $214.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 363 | $801,356 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 17 | $540,512 |
| Sage Therapeutics, LLC | 64 | $515,904 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 50 | $169,153 |
| Boehringer Ingelheim | 11 | $157,645 |
| Alkermes, Inc. | 84 | $149,004 |
| Idorsia Pharmaceuticals US Inc | 121 | $65,867 |
| Supernus Pharmaceuticals, Inc. | 9 | $65,215 |
| Otsuka America Pharmaceutical, Inc. | 191 | $42,623 |
| Acadia Pharmaceuticals Inc | 1 | $18,615 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 36 | $8,366 |
| H. Lundbeck A S | 4 | $5,474 |
| Boehringer Ingelheim International GmbH | 8 | $1,484 |
| Lundbeck LLC | 129 | $1,017 |
| Takeda Pharmaceuticals U.S.A., Inc. | 82 | $608 |
| Vanda Pharmaceuticals Inc. | 24 | $409 |
| Sunovion Pharmaceuticals Inc. | 25 | $370 |
| Bausch Health US, LLC | 21 | $368 |
| Teva Pharmaceuticals USA, Inc. | 8 | $283 |
| Johnson & Johnson | 16 | $281 |
| Neurocrine Biosciences, Inc. | 12 | $243 |
| Eisai Inc. | 21 | $197 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| Novo Nordisk | 1 | $30 |
| Merck | 1 | $13 |
| Neuronetics, Inc. | 1 | $10 |
How this compares
$2,545,157 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Temecula
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.